Clearmind Medicine Cash Flow Statement 2021-2024 | CMND

Fifteen years of historical annual cash flow statements for Clearmind Medicine (CMND).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-8.62$-6.89$0.00
$0.02$0.02$0
$3.27$1.91$0
$3.29$1.93$0
$0$0$0
$0$0$0
$0$0$0
$-0.35$0.32$0
$-0.97$1.24$0
$-6.30$-3.72$0
$0$-0.01$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$-0.03$0$0
$-0.03$-0.01$0
$0$0$0
$-0.04$-0.07$0
$-0.04$-0.07$0
$11.71$0.58$0
$11.71$0.58$0
$0$0$0
$0$0$0
$11.66$0.51$0
$5.30$-3.24$0
$0.37$1.21$0
$0$0$0